Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konrad H Stopsack

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
European Urology|December 28, 2020
Reply to Johann S. de Bono, Maha Hussain, and Jinyu Kang's Letter to the Editor re: Konrad H. Stopsack. Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of Olaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.024Konrad H Stopsack
European Urology|October 5, 2020
Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of OlaparibKonrad H Stopsack
The Journal of Urology|March 17, 2021
Editorial CommentKonrad H Stopsack
European Urology|February 8, 2021
Statins and Prostate Cancer: Bias, Precision Medicine, or Population Health?Konrad H Stopsack
JAMA Oncology|December 12, 2024
Polygenic Risk Scores for Prostate Cancer: Informing Prevention or TherapyKonrad H Stopsack
Mayo Clinic Proceedings|June 29, 2019
Cumulative Doses of Ionizing Radiation From Computed Tomography: A Population-Based StudyKonrad H Stopsack, James R Cerhan
JAMA Oncology|February 6, 2016
Bilateral Foot GangreneKonrad H Stopsack, Mithun Vinod Shah
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 2023
The Imperative for Population-based Cancer Registration of All Metastatic CancersKonrad H Stopsack, Anna Plym, Lorelei A Mucci
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2023
Aggressive Prostate Cancer Is Preventable and so Are Racial DisparitiesKonrad H Stopsack, Lorelei A Mucci, Edward L Giovannucci
World Journal of Urology|August 6, 2016
Common medications and prostate cancer mortality: a reviewKonrad H Stopsack, Alexandra J Greenberg, Lorelei A Mucci
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
European Urology|December 28, 2020
Reply to Johann S. de Bono, Maha Hussain, and Jinyu Kang's Letter to the Editor re: Konrad H. Stopsack. Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of Olaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.024Konrad H Stopsack
European Urology|October 5, 2020
Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of OlaparibKonrad H Stopsack
The Journal of Urology|March 17, 2021
Editorial CommentKonrad H Stopsack
European Urology|February 8, 2021
Statins and Prostate Cancer: Bias, Precision Medicine, or Population Health?Konrad H Stopsack
JAMA Oncology|December 12, 2024
Polygenic Risk Scores for Prostate Cancer: Informing Prevention or TherapyKonrad H Stopsack
Mayo Clinic Proceedings|June 29, 2019
Cumulative Doses of Ionizing Radiation From Computed Tomography: A Population-Based StudyKonrad H Stopsack, James R Cerhan
JAMA Oncology|February 6, 2016
Bilateral Foot GangreneKonrad H Stopsack, Mithun Vinod Shah
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 2023
The Imperative for Population-based Cancer Registration of All Metastatic CancersKonrad H Stopsack, Anna Plym, Lorelei A Mucci
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2023
Aggressive Prostate Cancer Is Preventable and so Are Racial DisparitiesKonrad H Stopsack, Lorelei A Mucci, Edward L Giovannucci
World Journal of Urology|August 6, 2016
Common medications and prostate cancer mortality: a reviewKonrad H Stopsack, Alexandra J Greenberg, Lorelei A Mucci
Pageof 11